Safety and Efficacy of Delayed-release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from Asia-Pacific and Other Countries: Interim Analysis of the APEX Extension Study

被引：0
|
作者：
Saida, Takahiko [1 ]
Yamamura, Takashi [2 ]
Kondo, Takayuki [3 ]
Yun, Jang [4 ]
Li, Jie [4 ]
Forsythe, Beverley [4 ]
Sheikh, Sarah, I [4 ]
Zhu, Bing [4 ]
机构：
[1] Kyoto Min Iren Cent Hosp, Kansai Multiple Sclerosis Ctr, Kyoto, Japan
[2] Natl Ctr Neurol & Psychiat NCNP, Tokyo, Japan
[3] Kansai Med Univ, Med Ctr, Osaka, Japan
[4] Biogen, Cambridge, MA USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.363
引用
收藏
页数：3
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF DELAYED-RELEASE DIMETHYL FUMARATE FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gasche, D.
    Restovic, G.
    Casado, V
    Ramirez-Boix, P.
    Martinez Lopez, J.
    VALUE IN HEALTH, 2015, 18 (07) : A755 - A755
  • [42] MRI Outcomes at Seven Years in Relapsing-Remitting Multiple Sclerosis Patients Treated With Delayed-release Dimethyl Fumarate in DEFINE, CONFIRM, and ENDORSE
    Arnold, Douglas L.
    Fox, Robert J.
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Yousry, Tarek
    MacManus, David
    Yang, Lili
    Riester, Katherine
    Taylor, Catherine
    Fay, Monica
    NEUROLOGY, 2017, 88
  • [43] Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)
    Cohan, Stanley L.
    Moses, Harold
    Calkwood, Jonathan
    Tornatore, Carlo
    LaGanke, Chris
    Smoot, Kyle E.
    Meka, Venkata
    Okwuokenye, Macaulay
    Hotermans, Christophe
    Mendoza, Jason P.
    Mann, Monica K.
    Meltzer, Leslie A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 22 : 27 - 34
  • [44] Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE)
    Gold, Ralf
    Schlegel, Eugen
    Elias-Hamp, Birte
    Albert, Christian
    Schmidt, Stephan
    Tackenberg, Bjoern
    Xiao, James
    Schaak, Tom
    Salmen, Hans Christian
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [45] Effect of delayed-release dimethyl fumarate on cognition in Italian patients with relapsing remitting multiple sclerosis: the phase 4 StarTec study
    Zipoli, V.
    Tortorella, P.
    Goretti, B.
    Morra, V. Brescia
    Gallo, P.
    Zaffaroni, M.
    Onofrj, M.
    Cocco, E.
    Pozzilli, C.
    Trojano, M.
    Amato, M. P.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 198 - 199
  • [46] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
    Michelle Allan
    Lindsay Grant
    Neurology and Therapy, 2020, 9 : 85 - 92
  • [47] Safety and tolerability of delayed-release dimethyl fumarate administered as add-on therapy to beta interferons or glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients
    Viglietta, V.
    Vollmer, T.
    Zhang, R.
    Novas, M.
    Sheikh, S. I.
    Fox, R. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 373 - 373
  • [48] Safety and tolerability of delayed-release dimethyl fumarate administered as add-on therapy to beta interferons or glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients
    Viglietta, V.
    Vollmer, T.
    Zhang, R.
    Novas, M.
    Sheikh, S. I.
    Fox, R. J.
    JOURNAL OF NEUROLOGY, 2014, 261 : S250 - S250
  • [49] Efficacy of delayed-release dimethyl fumarate for relapsing-remitting multiple sclerosis using a composite measure of disability: integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Bar-Or, A.
    Gold, R.
    Fox, R. J.
    Phillips, J. T.
    Giovannoni, G.
    Kappos, L.
    Havrdova, E.
    Hutchinson, M.
    Potts, J.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 303 - 304
  • [50] Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments
    Forci, B.
    Mariottini, A.
    Mechi, C.
    Magnani, E.
    Barilaro, A.
    Falcini, M.
    Palumbo, P.
    Massacesi, L.
    Repice, A. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 490 - 490
12345